Tehran – Iran’s Razi Vaccine and Serum Research Institute and representatives from the Philippine private sector have mapped out new opportunities for collaboration in pharmaceuticals and biologics, covering both trade and regulatory aspects.

 

The virtual meeting brought together officials from Razi Institute and a leading Philippine biologics company.

 

Both sides stressed the importance of strengthening commercial ties and expanding joint initiatives in the development, production, and distribution of vaccines and other biologic products.

 

Organized by Razi Institute’s Commercial Affairs Department, the session included experts from the institute’s commercial, international, and viral vaccine divisions. Philippine delegates outlined market demands and regulatory requirements, laying the groundwork for continued discussions and potential bilateral agreements.

 

The meeting highlighted Razi Institute’s commitment to advancing international partnerships and supplying high-quality vaccines to meet global health needs.